Archive

This in vitro study evaluated short-term extremely low frequency electromagnetic field (ELF-EMF) exposure and silver nanoparticles (AgNPs), alone and combined, for antibacterial effects and apoptosis induction in MCF-7 breast cancer cells. The authors report time-dependent reductions in bacterial viable counts, with…

This in vitro study evaluated 50 Hz, 70 G electromagnetic field exposure in combination with temozolomide (TMZ) in T98 and A172 glioblastoma cell lines. The authors report that EMF plus TMZ increased cell death and reduced migration potential compared with controls. They also report increased p53 gene expression and…

This materials proof-of-concept study explored using radiofrequency EMF to heat magnetic nanoparticles dispersed in PLLA to modulate polymer properties. Heating was monitored by infrared camera, and polymer changes were assessed by differential scanning calorimetry and nanoindentation. The authors report that EMF…

This laboratory study examined radiofrequency EMF exposure between 1 and 5.9 GHz as a method to control yeast growth relevant to food spoilage. The authors report reduced yeast viability at all tested frequencies and note that antenna-to-sample distance affected the outcome. Electron microscopy findings are described…

This animal and in vitro study examined ELF magnetic field exposure in a mouse breast tumor model and a breast cancer cell line. The authors report tumor growth suppression and reduced expression of Ki-67, CD31, VEGFR2, and MMP-9 after exposure. They also report increased IFN-γ and TNF-α and increased…

This in vitro study tested how varying ELF-EMF parameters (frequency, flux density, duration, and continuous vs switching exposure) affect breast cancer and normal breast epithelial cell lines. The authors report that an optimized switching exposure pattern (7.83 ± 0.3 Hz, 1 mT) reduced viability of MDA-MB-231 cells…

This article reviews Italian jurisprudence on alleged occupational tumours linked to RF EMF exposure (notably from wireless phones), with some cases also involving other RF sources or ELF magnetic fields. It contrasts court decisions that recognized occupational causation with others that rejected it, emphasizing how…

This in vitro study exposed murine microglial (N9) and human neuroblastoma (SH-SY5Y) cells to ELF-modulated 935 MHz RF-EMF at 4 W/kg for 2 or 24 hours. The authors report no changes in apoptosis, cell viability, or AIF across conditions. They report increased ATG5 after 24 hours and a transient glutathione increase…

This exposure assessment measured RF-EMF levels in 21 state hospitals in Samsun Province, Turkey using short-term, long-term, and band-selective approaches across 100 kHz–3 GHz (total) and 27 MHz–3 GHz (band-selective). The study reports that the ICTA 3 V/m limit was exceeded in at least some hospital measurements,…

This study evaluated whether adding extremely low frequency electromagnetic field (ELF-EMF) exposure to a rehabilitation program affects apoptosis-related gene expression in post-stroke patients. Forty-eight patients (3–4 weeks post-incident) were divided into ELF-EMF and non-ELF-EMF groups, with the ELF-EMF group…

This in vitro study evaluated whether extremely low-frequency EMF exposure (100 Hz, 100 G) modifies the effects of temozolomide (100 µM) in human glioblastoma U87 cells over 120–144 hours. The authors report that combined treatment reduced stemness-associated markers (Nestin, CD133, Notch4) and increased GFAP…

This study describes a therapeutic use of athermal, amplitude-modulated RF EMF (27.12 MHz) at breast cancer-specific frequencies to target breast cancer brain metastases. The abstract reports tumor growth suppression in animal models and durable regression in one patient with triple negative breast cancer brain…